ReviewOncoTargets and therapy2019

Recent Progress in Rare Oncogenic Drivers and Targeted Therapy For Non-Small Cell Lung Cancer.

Yijia Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.